CareDx (CDNA) Reports In-Line Q3 EPS

CareDx (NASDAQ: CDNA) reported Q3 EPS of ($0.06), in-line with the analyst estimate of ($0.06). Revenue for the quarter came in at $53.4 million versus the consensus estimate of $53.01 million.

For earnings history and earnings-related data on CareDx (CDNA) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Sunstone Hotel Investors to sell Hyatt Regency San Francisco for $279M
• RBC Capital Starts Molina Healthcare (MOH) at Sector Perform